Aptose Exercises Early Option for CG-806 License From CrystalGenomics
SAN DIEGO and SEOUL, South Korea, May 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS) and CrystalGenomics, Inc. (KOSDAQ:083790) today announced that Aptose exercised its option under the 2016 Option Agreement to exclusively …